176 related articles for article (PubMed ID: 241653)
1. Centrally induced hypotensive effects of beta-adrenergic blocking drugs.
Garvey HL; Ram N
Eur J Pharmacol; 1975; 33(2):283-94. PubMed ID: 241653
[TBL] [Abstract][Full Text] [Related]
2. Comparative antihypertensive effects and tissue distribution of beta adrenergic blocking drugs.
Garvey HL; Ram N
J Pharmacol Exp Ther; 1975 Jul; 194(1):220-33. PubMed ID: 1151751
[TBL] [Abstract][Full Text] [Related]
3. Studies on the cardiovascular effects of pindolol in DOCA/saline hypertensive rats.
Buckingham RE; Hamilton TC; Robson D
Br J Pharmacol; 1977 Jul; 60(3):461-9. PubMed ID: 19118
[TBL] [Abstract][Full Text] [Related]
4. Effect of autonomic neural influences on the cardiovascular changes induced by coronary occlusion.
Corr PB; Gillis RA
Am Heart J; 1975 Jun; 89(6):767-74. PubMed ID: 1130269
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of beta-adrenoreceptor blocking agents after intracerebroventricular administration in conscious normotensive cats.
Day MD; Roach AG
Clin Exp Pharmacol Physiol; 1974; 1(4):333-9. PubMed ID: 4156505
[No Abstract] [Full Text] [Related]
6. [Comparative action of adrenergic beta-blockers on cardiac automatism and auriculoventricular conduction in the nonanesthetized dog].
Duchêne-Marullaz P; Boucher M; Delaigue R; Kantelip JP; Gueorguev G
Nouv Presse Med; 1978 Sep; 7(31):2689-96. PubMed ID: 30944
[No Abstract] [Full Text] [Related]
7. Intrinsic sympathomimetic activity and the effects of beta-adrenergic blocking drugs on vulnerability to ventricular fibrillation.
Raeder EA; Verrier RL; Lown B
J Am Coll Cardiol; 1983 Jun; 1(6):1442-6. PubMed ID: 6133890
[TBL] [Abstract][Full Text] [Related]
8. The influence of the intrinsic sympathomimetic activity of beta-adrenoceptor antagonists on haemodynamic effects in anaesthetized dogs.
Wale JL; Austin M; Conway J; Reeves M
Clin Exp Pharmacol Physiol; 1979; 6(1):11-9. PubMed ID: 32981
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of chronotropic and inotropic effects of different beta adrenolytic drugs].
Cheymol G; Mouillé P; Laubie M; Schmitt H
C R Seances Soc Biol Fil; 1972; 166(6):823-8. PubMed ID: 4143908
[No Abstract] [Full Text] [Related]
10. The brain as a possible site for the cardiovascular effects of beta-adrenoceptor blocking agents in cats.
Day MD; Roach AG
Clin Sci Mol Med Suppl; 1975 Jun; 2():269s-272s. PubMed ID: 28878
[TBL] [Abstract][Full Text] [Related]
11. [Hemodynamic effects of some beta-adrenergic blocking agents in conscious spontaneously hypertensive rats (author's transl)].
Matsunaga K; Ueda M
Nihon Yakurigaku Zasshi; 1981 Jun; 77(6):597-604. PubMed ID: 6116655
[TBL] [Abstract][Full Text] [Related]
12. Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
Boucher M; Duchêne-Marullaz P; Moundanga JL
Br J Pharmacol; 1986 Sep; 89(1):119-27. PubMed ID: 2879587
[TBL] [Abstract][Full Text] [Related]
13. beta-Adrenoceptor blocking drugs and isoprenaline: central effects on cardiovascular parameters.
Cohen Y; Lindenbaum A; Midol-Monnet M; Porquet D; Wepierre J
Br J Pharmacol; 1979 Mar; 65(3):389-94. PubMed ID: 34457
[TBL] [Abstract][Full Text] [Related]
14. Some cardiovascular effects of timolol a new beta-adrenergic blocking agent.
Scriabine A; Torchiana ML; Stavorski JM; Ludden CT; Minsker DH; Stone CA
Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):76-93. PubMed ID: 4148410
[No Abstract] [Full Text] [Related]
15. Cardiovascular studies of 5-(3-tert-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a new potent beta-adrenergic blocking agent.
Yabuochi Y; Kinoshita D
Jpn J Pharmacol; 1974 Dec; 24(6):853-61. PubMed ID: 4618580
[TBL] [Abstract][Full Text] [Related]
16. Effect of propranolol of vascular responses to sympathetic nerve stimulation and plasma renin activity in mongrel dogs.
Lokhandwala MF; Asaad M; Buckley JP
Eur J Pharmacol; 1976 Jul; 38(1):141-7. PubMed ID: 8318
[TBL] [Abstract][Full Text] [Related]
17. Beta-adrenergic blockade and atrio--ventricular conduction impairment.
Giudicelli JF; Lhoste F; Boissier JR
Eur J Pharmacol; 1975 Apr; 31(2):216-25. PubMed ID: 238853
[TBL] [Abstract][Full Text] [Related]
18. Cardiac electrophysiologic properties of dl-propranolol, d-propranolol, l-propranolol and dl-pindolol in anesthetized dogs.
Jaillon P; Hecklé J; Weissenburger J; Cheymol G
J Pharmacol Exp Ther; 1980 Feb; 212(2):347-53. PubMed ID: 6101348
[No Abstract] [Full Text] [Related]
19. Estimation of cardiodepressant potency of nadolol, alprenolol, propranolol and pindolol, beta-blocking agents, in heart-lung preparation and blood-perfused excised papillary muscle preparation of the dog.
Ono H; Kanazawa Y; O'Hara N; Hashimoto K
Jpn J Pharmacol; 1984 Dec; 36(4):507-17. PubMed ID: 6151997
[TBL] [Abstract][Full Text] [Related]
20. Influence of acetylsalicylic acid on acute circulatory effects of the beta-blocking agents pindolol and propranolol in humans.
Sziegoleit W; Rausch J; Polák G; György M; Dekov E; Békés M
Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):423-30. PubMed ID: 7141761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
